Pharmaceutics | Free Full-Text | Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants
Neurobiology of Kratom and its main alkaloid mitragynine
Recreational Drug Kratom Hits the Same Brain Receptors as Strong Opioids - Scientific American
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Mitragynine - Wikipedia
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions | Scientific Reports
Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom | ACS Chemical Neuroscience
Molecules | Free Full-Text | Biased Opioid Ligands
Medicines | Free Full-Text | Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
Mitragynine - Wikipedia
G protein‐biased kratom‐alkaloids and synthetic carfentanil‐amide opioids as potential treatments for alcohol use disorder - Gutridge - 2020 - British Journal of Pharmacology - Wiley Online Library
The science behind kratom's strange leaves
Kratom - Proteopedia, life in 3D
Evaluating kratom alkaloids using PHASE | PLOS ONE
Frontiers | Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder
Opioid-based plant might not be best solution for those seeking to curb habitual alcohol use - Purdue University News
Pharmacological characterization of kratom derivatives at the µ, δ, and... | Download Scientific Diagram
Site selective C–H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy | Nature Communications
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions | Scientific Reports
Kratom | National Institute on Drug Abuse (NIDA)
Influence of G protein-biased agonists of μ-opioid receptor on addiction-related behaviors | SpringerLink
Frontiers | Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Kratom (Mitragyna speciosa) drug profile | www.emcdda.europa.eu
